pioglitazone has been researched along with Urinary Lithiasis in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z | 1 |
Yuan, P | 1 |
Sun, X | 1 |
Tang, K | 1 |
Liu, H | 1 |
Han, S | 1 |
Ye, T | 1 |
Liu, X | 1 |
Yang, X | 1 |
Zeng, J | 1 |
Yan, L | 1 |
Xing, J | 1 |
Xiao, K | 1 |
Ye, Z | 1 |
Xu, H | 1 |
Yasui, T | 1 |
Okada, A | 1 |
Hamamoto, S | 1 |
Ando, R | 1 |
Taguchi, K | 1 |
Tozawa, K | 1 |
Kohri, K | 1 |
1 review available for pioglitazone and Urinary Lithiasis
Article | Year |
---|---|
Pathophysiology-based treatment of urolithiasis.
Topics: Animals; Cardiovascular Diseases; Cholesterol, Dietary; Diabetes Mellitus, Type 2; Disease Models, A | 2017 |
1 other study available for pioglitazone and Urinary Lithiasis
Article | Year |
---|---|
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Binding Sites; Calcium Oxalate; Crystallization; Disea | 2019 |